Core Insights - Prenetics Global Limited (NASDAQ: PRE) is transitioning from a diagnostics company to a health sciences company, driven by strong sales growth of its product IM8 [1] Company Overview - Prenetics is characterized as a young and small company, indicating potential for growth and development in the health sciences sector [1] Sales Performance - The transition to a health sciences company is primarily based on the robust sales growth of IM8, suggesting a successful product performance that could enhance the company's market position [1]

Strengthens Balance Sheet with Over $60 Million in Cash1, Excluding Bitcoin TreasuryDavid Beckham Co-Founded IM8 on Track to Achieve $100 Million ARR in First Year, Becoming One of the Fastest-Growing Supplement Brands in the History of the IndustryBitcoin Treasury Grows to 255 BTC with 1 BTC Per Day Purchase Strategy Since August, NAV now at $31.6 Million, with an unrealized profit of $3.86 Million CHARLOTTE, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer ...

- Keynote: “IM8: The World’s Fastest-Growing Supplement Brand Powering Our Bitcoin Treasury - Prenetics currently holds 246 BTC with a NAV of $28M - Prenetics has $63.5m of cash1 CHARLOTTE, N.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”), a leading consumer health sciences company, today announced Chief Executive Officer, Danny Yeung will deliver a keynote address at Token 2049, one of the world’s premier crypto and blockchain conferences, taking place in Singap ...